Mark Ramirez's Articles - Free Article Search | News Article | Health Article | Science Article
Search:

Mark Ramirez's Articles

Display Category|Title|Newest|Oldest
  • 1930’s Remedy Curing Diabetes?
    Mary Vernon has been using a treatment that has been abandoned since the 1930’s. The worst part, the treatment that is the opposite of guidelines set by the American Diabetes Association, has been working.
  • 5 Tips to Stay Healthy this Winter
    If you are trying to stay healthy through the holidays this winter, here are a few tips to fight off those few pounds that always sneak up on us this time of year.
  • 6 Quick Tips to Avoid An Rx Mix-up
    To prevent a mix-up from ever happening to you or the ones you are caring for, here are a few tips to follow when you receive a new prescription in the mail from your online source.
  • ADHD: Fact or Fiction?
    This article addresses both facts and myths associated with ADHD.
  • All Diets are Created Equal
    The results of a new study examining the effectiveness of diets is out, and point out that most all diets help dieters lose weight the same. The study led by Dr. Michael Dansinger of the Tufts-New England Medical Center in Boston found that the effect of dietary counseling for weight loss on average, resulted in weight loss of around 6 percent of patients initial body weight after one year, compared with people not involved in formal weight loss programs.
  • Another New Study Rips Avandia
    According to analysis published by the the Cochrane Library, “A new meta-analysis of 18 studies finds that Glaxo’s diabetes pill doesn’t “positively influence” the health of diabetics, reduce death, improve quality of life, but does contribute to weight gain, swelling, heart risks and broken bones.
  • Avandia Increases Risk of Heart Attack
    The widely prescribed diabetes drug Avandia was found in a recent study to increase the risk of heart attack in patients by 43%. The findings of the recent study will be published in June 14 issue of The New England Journal of Medicine.
  • Avandia Related Heart Attacks Surge
    According to reports by the Associated Press, Avandia side effects reports have tripled in the month after the report that the blockbuster drug used to treat diabetes drastically raised users risk of heart attack.
  • Birth Control Pills: They Don’t Make’em Like They Use To
    Do to the deteriorated effectiveness of recent birth control medication, the FDA has decided to assemble a panel in order to determine if new contraceptive medication should be required to meet a higher standard of quality.
  • Can Soda be Healthy?
    Over the last several years, the soda industry has taken a large hit. Studies have shown sodas to be a black hole of nutrition, and the cause of many health woes. Parents have begun to force public schools to do away with soda machines. Fast food chains have been forced to provide healthier alternatives the sugary sin drink. So what are soda companies to do in the face of mounted opposition? Get healthy.
  • Congress Poised to Hand Over Tobacco Oversight to FDA
    The US Congress is on the verge of passing a bill that will give the US Food and Tobacco Agency the authority to regulate tobacco. Expert analysis on whether is still back and forth on whether the bill will affect the actual use of tobacco.
  • Could RX Master Help You Conquer Your Medication?
    The Rx Master is a carrying case for your medications, with built in pill drawers keeping each day’s medication separate. On top of those compartments sits a computer that will inform you of any possible interactions with other drugs or food you are consuming, side affects, and risk of addiction.
  • Expanded Approval of Humira by the FDA Allows for Extended Monopoly
    This article talks about the FDA's recent expanded approval of the psoriatic arthritis drug Humira.
  • FDA Approves Psoriatic Arthritis Drug For Chrohn’s Disease
    The popular drug Humira which is currently used to treat Psoriatic Arthritis was approved on Feb. 27 by the FDA to treat adult Chrohn’s disease.
  • FDA Calls for “Black Box” on Controversial Antibiotic
    The FDA announced that the antibiotic Ketek which is used to treat pneumonia must come with a new “black box” warning.
  • FDA Drug Approval Process Flawed
    This article uses the case of Vioxx being taken off the market as an example to show the deceit and corruption of the FDA.
  • FDA OK’s New Alzheimer’s Patch
    On July 9th, the Swiss Drug Maker Novartis received approval from the American Food and Drug Administration to begin selling its Exelon skin patch used to treat Alzheimer’s.
  • FDA Pushes to Broaden Warnings On Anti-Depressants
    The FDA is urging that a new warning be placed on the labels of all anti-depressants warning of an increased risk of suicidal thoughts and behavior. The current warning label warns of a increase of suicidal thoughts and behavior in children 18 and younger, but the FDA says that the warning should be expanded to also include young adults from 18-24 years old.
  • FDA Releases New Plan to Shape-Up System
    In response to recent heavy criticism received by the FDA, the FDA unveiled a new set of codes on Tuesday hoping to upgrade the safety operations found in the US.
  • FDA’s New Survey Says Trust in FDA Renewing
    A new poll says that public trust in the FDA is beginning to rebound after a steady decline the last 2 years, but there is still much more work to do.
  • Fish Helps Statins Protect Heart
    A new study reported in the March 31 issue of The Lancet found that the Omega 3 fatty acids usually found in fish and fish oil increase a patients chance of avoiding heart trouble than taking statins alone. The study which was conducted in Japan is the first test of its kind.
  • House Hopes to Use Leverage to Negotiate Lower Drug Prices
    The enactment of Nanci Pelosi’s first hundred hours has begun, and house democrats are searching for ways to fulfill her goal of lowering the price of prescription medication for seniors using Medicare.
  • Is the FDA Being Bought by Drugmakers?
    The FDA commissioner defended the fee paid by the drug makers that fund the review and approval process of their medication claiming that the money received does not sway the approval process.
  • Merck to Cut Spending by 9% by the End of the Year
    Merck will downsize its spending on promotions and sales force by 9% the end of the year. Sources at Merck have stated that spending will include job losses although final figures had not been agreed upon.
  • New Birth Control Pills More Likely to Cause Blood Clots
    A recent study found that newer third generation birth control pills double your risk of contracting a potentially fatal blood clot compared to older birth control pills.
  • New Drug Approved to Treat ADHD
    The new drug Vyvanse received approval on Monday by the Food and Drug Administration to affectively treat Attention Deficit Hyperactivity Disorder.
  • New Options for Rheumatoid Arthritis
    A new era for rheumatoid arthritis is beginning to unfold, leading the charge is several new drugs which are giving arthritis sufferers new options that many have never enjoyed.
  • New Study Shows Diabetes Drug Avandia Prevents Diabetes
    A recent study shows that the drug Avandia which is used to treat type 2 diabetes also helps to prevent patients from acquiring diabetes. In a 3 year clinical study out of Denmark that included 21 different countries, people who were at high risk to acquire diabetes were 60% less likely to contract the disease while taking Avandia.
  • New Weight Loss Drug Keeps Users Looking For the Toilet
    Alli, the first FDA approved OTC diet aid has hit shelves, and is guaranteed to be a big hit. The new medication promises to enhance weight loss 50% more than dieting alone by preventing the body from digesting the fat on ingested food. The only problem is the leakage.
  • Not Just Big Pharma: Biotech Companies Fighting Over Drug Patents
    Barr Pharmaceuticals is lobbying for a US law that would allow the sale of copied medicines made by the biotech industry. Barr is dispatching almost a dozen representatives along with many other generic drug lobbyists, to try to pass their law.
  • Oxycotin Ruled Addictive, Drug Makers Fined for Misleading Public
    Last Friday, U.S. District Judge James Jones ordered Purdue Pharma L.P., the maker of OxyContin, to pay $634.5 million in fines for misleading the public about the addictiveness of the painkiller.
  • Study Suggests Vioxx Risks were Covered Up
    Results from a new study show that increased heart risks that were produced by Merck's Vioxx began immediately, and not after 18 months as the company has stated. The study could potentially strike a whole in Merck’s defense, who is still involved in ongoing litigation.
  • They Don’t Make’em Like They Use To
    This article shows why todays medication is less efective than medication produced 20 years ago.
  • Uninsured Americans Raise Medicare Expenditures
    A new study shows that Americans who were not insured before the age of 65 and gained access to Medicare cost the system exponentially more money than those who were previously insured with prior health insurance.
  • Vitamins to Improve Eyesight Give Blurry Results
    Since you were a child, you have been told to “eat your carrots, so you can see better.” It has been thought for generations that beta carotene can be taken to better increase your eyesight, but a recent study proves otherwise.
  • Why it Took 10 Years to Approve Aricept for Use On Severe Alzheimer’s
    This article exsplains why it took 10 years to approce Aricept for its full range of uses.
  • Zofran Generic Approved
    This article talks about the recent FDA approval of the generic form of Zofram to be produced by Dr. Reddy Laboratories of Bridgewater, N.J.; Kali Laboratories of Somerset, N.J.; and Roxane Laboratories of Columbus, Ohio.
Member/Author Login
Concert Tickets
loft conversion london
Merchant Card Account

Article Directory
Ask Me Tips
Tata Nano Car
Submit Articles
Top Authors
Most Popular Articles
Submission Guidelines
Ezine Notifications
Article RSS Feeds
Easy Life Tips
Links
Technology Info
New Stuff
About Us
Site Blog
Forum
Tech Information

Watch Videos

Copy Right © 2006 christiannotepad.com All Right Reserved

    Use of our service is protected by our Privacy Policy and Terms of Service   Subscribe Feed Contact Us
 
 

Powered by Article Dashboard